Yuko Kato^1,2,3, Satoru Miyagi^2,3, Atsunori Saraya³, Wakako Kuribayashi^3,4, Daisuke Shinoda^3,4, Shuhei Koide^3,4, Yumi Matsuzaki^1,2, Atsushi Iwama^3,4 (1.PuREC Co. Ltd, 2.Department of Life Science, Faculty of Medicine, Shimane University, 3.Department of Cellular and Molecular Medicine, Chiba University, 4.Division of Stem Cell and Molecular Medicine, University of Tokyo)

Daisuke Kurotaki¹, Pedro Rocha², Kairong Cui³, Jun Nakabayashi⁴, Keita Saeki⁵, Keji Zhao³, Keiko Ozato⁵, Tomohiko Tamura^1,4 (1.Dept. Immunol., Yokohama City Univ. Grad. Sch. Med., Yokohama, Japan, 2.Unit Genome Struct. Regul., NICHD, NIH, Bethesda, USA, 3.Syst. Biol. Ctr., NHLBI, NIH, Bethesda, USA, 4.Adv. Med. Res. Ctr., Yokohama City Univ., Yokohama, Japan, 5.Prog. Genomics Differ., NICHD, NIH, Bethesda, USA)

Tomomasa Yokomizo¹, Takako Ideue¹, Mineo Kurokawa², Norio Komatsu³, Motomi Osato⁴, Toshio Suda¹ (1.IRCMS, Kumamoto Univ., Kumamoto, Japan, 2.Dept. of Hematol. and Oncol., Univ. of Tokyo, Tokyo, Japan, 3.Hematol., Juntendo Univ., Tokyo, Japan, 4.CSI, National Univ. of Singapore, Singapore)

Hesham Nasser¹, Partho Adhikary¹, Amira Abdeldaim¹, Osamu Noyori¹, Hitoshi Takizawa², Ryusho Kariya¹, Seiji Okada¹, Shinya Suzu¹ (1.Joint Research Center for Human Retrovirus Infection, Kumamoto Univ, 2.IRCMS, Kumamoto Univ)

Toshiyuki Yamane (Stem Cell & Dev. Biol., Mie Univ., Tsu, Japan)

Tatsuya Morishima^1,2, Koichi Takahashi⁴, Kenji Tokunaga⁵, Masao Matsuoka⁵, Toshio Suda^3,6, Hitoshi Takizawa¹ (1.Laboratory of Stem Cell Stress, IRCMS, Kumamoto Univ, Kumamoto, Japan, 2.Laboratory of HSC Engineering, IRCMS, Kumamoto Univ, Kumamoto, Japan, 3.Laboratory of Stem Cell Regulation, IRCMS, Kumamoto Univ, Kumamoto, Japan, 4.The University of Texas MD Anderson Cancer Center, TX, USA, 5.Department of Haematology, Kumamoto University School of Medicine, Kumamoto, Japan, 6.Cancer Science Institute of Singapore, National University of Singapore, Singapore)